These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

155 related articles for article (PubMed ID: 4997827)

  • 1. [An experimental study on the antituberculous activity of rifampicin].
    Toyoara M
    Kekkaku; 1971 Jun; 46(6):211-6. PubMed ID: 4997827
    [No Abstract]   [Full Text] [Related]  

  • 2. [Short term chemotherapy of tuberculosis. Bactericidal mechanisms in short term chemotherapy].
    Mitchison DA; Dickinson JM
    Bull Int Union Tuberc; 1978 Dec; 53(4):270-5. PubMed ID: 115526
    [No Abstract]   [Full Text] [Related]  

  • 3. Mode of action of antituberculous agents and ultrastructure of mycobacteria.
    Oka S; Yamaguchi J; Ariji F; Madokoro K; Kumano N
    Sci Rep Res Inst Tohoku Univ Med; 1971 Jul; 18(1):7-13. PubMed ID: 5005200
    [No Abstract]   [Full Text] [Related]  

  • 4. Intracellular growth and drug susceptibility of Mycobacterium tuberculosis in macrophages.
    Chanwong S; Maneekarn N; Makonkawkeyoon L; Makonkawkeyoon S
    Tuberculosis (Edinb); 2007 Mar; 87(2):130-3. PubMed ID: 16860611
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Increasing drug resistance of Mycobacterium tuberculosis isolates in Ontario, Canada, 1987-1998.
    Remis RS; Jamieson F; Chedore P; Haddad A; Vernich L
    Clin Infect Dis; 2000 Aug; 31(2):427-32. PubMed ID: 10987700
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Experimental evidence for Mycobacterium tuberculosis persistence in M. tuberculosis-infected H37RV mice in the treatment with 3 first-line drugs (rifampicin, isoniazid, pyrazinamide)].
    Smirnova TG; Chernousova LN; Andreevskaia SN; Nikolaeva GM
    Probl Tuberk Bolezn Legk; 2004; (3):32-7. PubMed ID: 15338898
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Detection of rifampicin and isoniazid resistances of Mycobacterium tuberculosis strains by particle counting immunoassay (PACIA).
    Drowart A; Cambiaso CL; Huygen K; Serruys E; Portaels F; Jann E; Van Vooren JP
    Int J Tuberc Lung Dis; 1997 Jun; 1(3):284-8. PubMed ID: 9432378
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Experimental evaluation of the antimycobacterial activity of rifampicin].
    Ninni A; Scoles E; Iodice F; Razza I
    Arch Tisiol Mal Appar Respir; 1968 Apr; 23(4):315-28. PubMed ID: 4981410
    [No Abstract]   [Full Text] [Related]  

  • 9. [On the bactericidal activity in vivo of Rifampicin alone or associated with isoniazid].
    Nitti V; Ninni A; Natali P
    Arch Tisiol Mal Appar Respir; 1967 Oct; 22(10):859-70. PubMed ID: 4975183
    [No Abstract]   [Full Text] [Related]  

  • 10. [The Mycobacteria Growth Indicator Tube (MGIT) is useful for anticipating the resistance of Mycobacterium tuberculosis to rifampicin but not to isoniazid].
    Avendaño D; López B; Símboli N; Masciotra N; Barrera L
    Rev Argent Microbiol; 2001; 33(4):197-202. PubMed ID: 11833250
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Molecular medicine and treatment of tuberculosis].
    Perel'man MI; Khomiakov IuN; Kiselev VI; Severin ES; Pal'tsev MA
    Probl Tuberk; 2001; (5):5-7. PubMed ID: 11588966
    [No Abstract]   [Full Text] [Related]  

  • 12. [Experimental antitubercular activity of rifampicin, a derivative of rifamycin SV].
    Grumbach F; Rist N
    Rev Tuberc Pneumol (Paris); 1967; 31(6):749-62. PubMed ID: 4988378
    [No Abstract]   [Full Text] [Related]  

  • 13. Rapid and simple MTT method for rifampicin and isoniazid susceptibility testing of Mycobacterium tuberculosis.
    Foongladda S; Roengsanthia D; Arjrattanakool W; Chuchottaworn C; Chaiprasert A; Franzblau SG
    Int J Tuberc Lung Dis; 2002 Dec; 6(12):1118-22. PubMed ID: 12546122
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Rapid, automated, nonradiometric susceptibility testing of Mycobacterium tuberculosis complex to four first-line antituberculous drugs used in standard short-course chemotherapy.
    Johansen IS; Thomsen VØ; Marjamäki M; Sosnovskaja A; Lundgren B
    Diagn Microbiol Infect Dis; 2004 Oct; 50(2):103-7. PubMed ID: 15474318
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Molecular mechanisms of mycobacterium tuberculosis strains resistance to rifampicin and isoniazid].
    Stepanshina VN; Panfertsev EA; Mitrofanova GN; Korobova OV; Stepanshin IuG; Shemiakin IG; Medvedeva IM
    Probl Tuberk; 2000; (1):32-6. PubMed ID: 10750428
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [The resistance rates of Mycobacterium tuberculosis strains to antituberculosis drugs: evaluation of two years' data in Aegean region, Turkey].
    Güneri S; Unsal I; Oztop A; Erkut M; Avkan Oğuz V; Ozgü A; Cakmak R
    Mikrobiyol Bul; 2004 Jul; 38(3):203-12. PubMed ID: 15490839
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Application of the Genotype MTBDR assay directly on sputum specimens.
    Hillemann D; Rüsch-Gerdes S; Richter E
    Int J Tuberc Lung Dis; 2006 Sep; 10(9):1057-9. PubMed ID: 16964801
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Rapid detection of rifampicin and isoniazid resistance in Mycobacterium tuberculosis by the direct thin-layer agar method.
    Robledo J; Mejia GI; Paniagua L; Martin A; Guzmán A
    Int J Tuberc Lung Dis; 2008 Dec; 12(12):1482-4. PubMed ID: 19017461
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Drug resistance in tuberculosis.
    Ebrahim GJ
    J Trop Pediatr; 2007 Jun; 53(3):147-9. PubMed ID: 17526511
    [No Abstract]   [Full Text] [Related]  

  • 20. [Effect of saturation of Mycobacterium tuberculosis--a theoretical basis of the method of mazimum concentration of tuberculostatic preparations].
    Bondarev IM
    Probl Tuberk; 1974; 52(6):58-64. PubMed ID: 4211415
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.